Literature DB >> 26209539

Pancreatic Cancer Metastases Harbor Evidence of Polyclonality.

Ravikanth Maddipati1, Ben Z Stanger2.   

Abstract

UNLABELLED: Studies of the cancer genome have demonstrated that tumors are composed of multiple subclones with varied genetic and phenotypic properties. However, little is known about how metastases arise and evolve from these subclones. To understand the cellular dynamics that drive metastasis, we used multicolor lineage-tracing technology in an autochthonous mouse model of pancreatic cancer. Here, we report that precursor lesions exhibit significant clonal heterogeneity but that this diversity decreases during premalignant progression. Furthermore, we present evidence that a significant fraction of metastases are polyclonally seeded by distinct tumor subclones. Finally, we show that clonality during metastatic growth-leading to either monoclonal or polyclonal expansion-differs based on the site of metastatic invasion. These results provide an unprecedented window into the cellular dynamics of tumor evolution and suggest that heterotypic interactions between tumor subpopulations contribute to metastatic progression in native tumors. SIGNIFICANCE: Studies of tumor heterogeneity indicate that distinct tumor subclones interact during cancer progression. Here, we demonstrate by lineage tracing that metastases often involve seeding by more than one clone and that subsequent cellular outgrowth depends on the metastatic site. These findings provide insight into clonal diversity and evolution in metastatic disease. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26209539      PMCID: PMC4657730          DOI: 10.1158/2159-8290.CD-15-0120

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  23 in total

1.  Notch signaling controls liver development by regulating biliary differentiation.

Authors:  Yiwei Zong; Archana Panikkar; Jie Xu; Aline Antoniou; Peggy Raynaud; Frederic Lemaigre; Ben Z Stanger
Journal:  Development       Date:  2009-04-15       Impact factor: 6.868

2.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

Authors:  Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

Review 3.  Clonal evolution in cancer.

Authors:  Mel Greaves; Carlo C Maley
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

4.  Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.

Authors:  Nabeel Bardeesy; Andrew J Aguirre; Gerald C Chu; Kuang-Hung Cheng; Lyle V Lopez; Aram F Hezel; Bin Feng; Cameron Brennan; Ralph Weissleder; Umar Mahmood; Douglas Hanahan; Mark S Redston; Lynda Chin; Ronald A Depinho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

5.  Evidence for the clonal origin of spontaneous metastases.

Authors:  J E Talmadge; S R Wolman; I J Fidler
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

6.  Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.

Authors:  Janel L Kopp; Guido von Figura; Erin Mayes; Fen-Fen Liu; Claire L Dubois; John P Morris; Fong Cheng Pan; Haruhiko Akiyama; Christopher V E Wright; Kristin Jensen; Matthias Hebrok; Maike Sander
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

Review 7.  Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis.

Authors:  Guoqiang Gu; Juliana R Brown; Douglas A Melton
Journal:  Mech Dev       Date:  2003-01       Impact factor: 1.882

8.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

9.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

10.  EMT and dissemination precede pancreatic tumor formation.

Authors:  Andrew D Rhim; Emily T Mirek; Nicole M Aiello; Anirban Maitra; Jennifer M Bailey; Florencia McAllister; Maximilian Reichert; Gregory L Beatty; Anil K Rustgi; Robert H Vonderheide; Steven D Leach; Ben Z Stanger
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

View more
  113 in total

Review 1.  The Emerging Link between Centrosome Aberrations and Metastasis.

Authors:  Gina M LoMastro; Andrew J Holland
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

2.  Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer.

Authors:  Yi Zhong; Anne Macgregor-Das; Tyler Saunders; Martin C Whittle; Alvin Makohon-Moore; Zachary A Kohutek; Justin Poling; Brian T Herbst; Breanna M Javier; Leslie Cope; Steven D Leach; Sunil R Hingorani; Christine A Iacobuzio-Donahue
Journal:  Clin Cancer Res       Date:  2016-09-16       Impact factor: 12.531

Review 3.  Understanding Disease Biology and Informing the Management of Pancreas Cancer With Preclinical Model Systems.

Authors:  Martin C Whittle; Sunil R Hingorani
Journal:  Cancer J       Date:  2017 Nov/Dec       Impact factor: 3.360

4.  EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration.

Authors:  Nicole M Aiello; Ravikanth Maddipati; Robert J Norgard; David Balli; Jinyang Li; Salina Yuan; Taiji Yamazoe; Taylor Black; Amine Sahmoud; Emma E Furth; Dafna Bar-Sagi; Ben Z Stanger
Journal:  Dev Cell       Date:  2018-06-18       Impact factor: 12.270

Review 5.  The promise of circulating tumor cells for precision cancer therapy.

Authors:  William L Hwang; Katie L Hwang; David T Miyamoto
Journal:  Biomark Med       Date:  2016-12-07       Impact factor: 2.851

Review 6.  Cell motility in cancer invasion and metastasis: insights from simple model organisms.

Authors:  Christina H Stuelten; Carole A Parent; Denise J Montell
Journal:  Nat Rev Cancer       Date:  2018-03-16       Impact factor: 60.716

Review 7.  Circulating tumor cells as "liquid biopsies" to understand cancer metastasis.

Authors:  Dennis Woo; Min Yu
Journal:  Transl Res       Date:  2018-07-17       Impact factor: 7.012

8.  Pancreatic Tumor Microenvironment.

Authors:  Kai Wang; Hong He
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 9.  Pancreatic cancer biology and genetics from an evolutionary perspective.

Authors:  Alvin Makohon-Moore; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Cancer       Date:  2016-07-22       Impact factor: 60.716

Review 10.  Tumour heterogeneity and resistance to cancer therapies.

Authors:  Ibiayi Dagogo-Jack; Alice T Shaw
Journal:  Nat Rev Clin Oncol       Date:  2017-11-08       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.